drugset / Trial / NCT00973973
Efficacy and Safety Study of Elagolix in Women With Endometriosis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate elagolix (NBI-56418) compared to placebo for its effects on endometriosis related pelvic pain and its safety.
Timeline
- Start
- 2009-10-12
- Primary completion
- 2010-09-22
- Completion
- 2010-09-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Elagolix | Small molecule | 150 mg | Oral |